(Anesth Analg. 2018;127:706–713)
Allogeneic blood transfusion is an important component in the treatment of postpartum hemorrhage. Short-term risks include acute transfusion reactions, hemolytic anemia, and transfusion-related acute lung injury, whereas long-term risks include immunosuppression. One method to reduce the need for allogeneic packed red blood cell (PRBC) transfusion after cesarean delivery (CD) is to use autologous blood transfusion obtained via intraoperative cell salvage (ICS). Consensus statements suggest that ICS is particularly beneficial in cases of anticipated massive blood loss—>20% or more of the patient’s estimated blood volume. In the current study, the authors assessed allogeneic transfusion rates before and after implementation of a targeted ICS infusion program in women undergoing CD at the Ningbo Women and Children’s Hospital (NWCH) in China.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.